Back to BlackRock, Inc. BlackRock, Inc.

CRBPCRBP
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CORBUS PHARMACEUTICALS HLDGS

BlackRock, Inc. holds 1.3M shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), worth $12.5M as of 2026-Q2. The position was increased (+390.0% shares). CRBP represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$12.5M

Current Shares

1.3M

Total Value Change

+$2.2M

Total Shares Change

+457,761

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+390.0%
$12.5M0.0%$9.38
45
2026-Q1
Increased
271,636
+1.3%
$2.6M0.0%$8.21
18
2025-Q4
Increased
268,046
+18.1%
$2.2M0.0%$8.01
21
2025-Q3
Decreased
226,898
-35.6%
$2.9M0.0%$12.26
0
2025-Q2
Decreased
352,409
-58.4%
$2.4M0.0%$7.40
0
2025-Q1
Decreased
846,062
-3.1%
$4.5M0.0%$5.52
0
2024-Q4
New
873,374
-
$10.3M0.0%$12.08
38

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used